[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@DoodadDoctor Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1989890812982013952.png) @DoodadDoctor Dr. Rajiv Doodad

Dr. Rajiv Doodad posts on X about $gpcr, $vktx, strong, $ptgx the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1989890812982013952/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1989890812982013952/c:line/m:interactions.svg)

- X Week XXXXX +100%

### Mentions: X [#](/creator/twitter::1989890812982013952/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1989890812982013952/c:line/m:posts_active.svg)


### Followers: XX [#](/creator/twitter::1989890812982013952/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1989890812982013952/c:line/m:followers.svg)

- X Week XX +167%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1989890812982013952/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1989890812982013952/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  XXXX% [stocks](/list/stocks)  XXXX%

**Social topic influence**
[$gpcr](/topic/$gpcr) #28, [$vktx](/topic/$vktx) #26, [strong](/topic/strong) 6.25%, [$ptgx](/topic/$ptgx) 6.25%, [$tvtx](/topic/$tvtx) 6.25%, [$cytk](/topic/$cytk) 6.25%, [$akro](/topic/$akro) 6.25%, [acquisition](/topic/acquisition) 6.25%, [$rvmd](/topic/$rvmd) 6.25%, [$pepg](/topic/$pepg) XXXX%

**Top accounts mentioned or mentioned by**
[@bigchodu](/creator/undefined) [@bioinvestor24](/creator/undefined) [@unsureoptimist](/creator/undefined) [@wallstsai](/creator/undefined) [@biotech2k1](/creator/undefined) [@getoutofmyway1](/creator/undefined) [@daytraderdex](/creator/undefined) [@logicalthesis](/creator/undefined) [@tradingsssss](/creator/undefined) [@unemon1](/creator/undefined) [@vulpescap](/creator/undefined) [@jfais20](/creator/undefined) [@andersresearch](/creator/undefined) [@bionavgator](/creator/undefined) [@coinbasedbtc](/creator/undefined) [@smx778939928](/creator/undefined) [@jw929204](/creator/undefined)

**Top assets mentioned**
[Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Travere Therapeutics, Inc. Common Stock (TVTX)](/topic/$tvtx) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Akropolis (AKRO)](/topic/$akro) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Novo-Nordisk (NVO)](/topic/$nvo) [Amgen, Inc. (AMGN)](/topic/$amgn) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Eli Lilly and Company (LLY)](/topic/$lly) [Synthetify (SNY)](/topic/$sny) [AltLayer (ALT)](/topic/$alt)
### Top Social Posts
Top posts by engagements in the last XX hours

"$GPCR topline take: Strong efficacy clean safety tolerability the only real overhang. XXXX% WL @ 120mg (Phase X dose) = competitive w/ oral GLP-1 class High-dose (180-240mg) hits 14-15% WL best-in-class oral range Safety clean (no DILI/QTc) AE d/c XXXX% @ 120mg = main miss but early titration data encouraging Net: Not perfect but clearly a viable Ph3 asset with leverage if tolerability improves - looking at a potential best in-class oral here"  
[X Link](https://x.com/DoodadDoctor/status/1998023600574550144)  2025-12-08T13:35Z XX followers, 1281 engagements


"PTXG has potential But I prefer $PTGX"  
[X Link](https://x.com/DoodadDoctor/status/1995205406076043660)  2025-11-30T18:56Z XX followers, 1556 engagements


"@BigChodu @Biotech2k1 lol I remember reading that smh. he does hold some good names though and I usually like his port better than some of the more followed experts on BioX. $TVTX is a winner"  
[X Link](https://x.com/DoodadDoctor/status/1995207481400996198)  2025-11-30T19:05Z XX followers, XXX engagements


"@LogicalThesis @tradingsssss Show $CYTK"  
[X Link](https://x.com/DoodadDoctor/status/1996377375249191305)  2025-12-04T00:33Z XX followers, XXX engagements


"@unemon1 @Vulpescap $AKRO was already known hence why there was only like XX% premium on the buyout"  
[X Link](https://x.com/DoodadDoctor/status/1996945929773973506)  2025-12-05T14:13Z XX followers, XX engagements


"It appears that BioX is struggling to grapple with $GPCR results and subsequent price action today because the vast majority has been long $VKTX + hyping it up as the top takeout candidate for M&A. Today stings - but acquisition price for $GPCR will be well over $XXX so there is still time to get a share of potential best-in-class oral GLP1 that market has been waiting for"  
[X Link](https://x.com/DoodadDoctor/status/1998044355144147011)  2025-12-08T14:57Z XX followers, XXX engagements


"@jfais20 @Anders_Research Just wait until that X% allocation to $RVMD plays out And while Im also long $PEPG it was down -XX% today lol. his returns are being decimated"  
[X Link](https://x.com/DoodadDoctor/status/1996010540355764400)  2025-12-03T00:16Z XX followers, XXX engagements


"@Bionavgator $MDGL is XXX% getting bought"  
[X Link](https://x.com/DoodadDoctor/status/1996808374013645153)  2025-12-05T05:06Z XX followers, XXX engagements


"Here's how players in the obesity-verse closed the day: $NVO $LLY $AMGN $VKTX $RHHBY $GPCR $SNY $ALT $GUTS $WVE"  
[X Link](https://x.com/DoodadDoctor/status/1998144428460880271)  2025-12-08T21:35Z XX followers, XXX engagements